TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive Capitol Hill: Advocates Lobby Congress To Close Medicare Loophole For Colonoscopy Coverage July 18, 2014
TCL Archive Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer July 31, 2009
TCL Archive HHS Inspector General: Busy Signals Greet One In Three Callers To 800-4-CANCER July 24, 1998
